We showed that circMTO1 could act as a tumor suppressor affecting the growth and invasion of CRC cells via regulating Wnt/beta-catenin signaling pathway, providing a novel potential biomarker and therapeutic target for CRC treatment.
CircMTO1 inhibits cell proliferation and invasion by regulating Wnt/beta-catenin signaling pathway in colorectal cancer.